Jakafi — Medical Mutual
Pediatric Acute Lymphoblastic Leukemia
Initial criteria
- Patient is age ≥ 12 years
 - Patient has steroid-refractory disease
 - Prescribed by or in consultation with a hematologist or oncologist
 
Approval duration
1 year
Pediatric Acute Lymphoblastic Leukemia
1 year